Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ABEO

Abeona Therapeutics (ABEO)

Abeona Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABEO
DateTimeSourceHeadlineSymbolCompany
02/13/20195:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOAbeona Therapeutics Inc
02/13/20191:26PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ABEOAbeona Therapeutics Inc
02/13/201911:47AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ABEOAbeona Therapeutics Inc
02/12/20199:38AMEdgar (US Regulatory)Schedule 13gNASDAQ:ABEOAbeona Therapeutics Inc
02/11/20194:05PMGlobeNewswire Inc.Abeona Therapeutics Appoints João Siffert, M.D. Chief Executive OfficerNASDAQ:ABEOAbeona Therapeutics Inc
02/01/20196:03AMGlobeNewswire Inc.Abeona Therapeutics präsentiert auf dem WORLDSymposium™ neue unterstützende Daten für neuartige GentherapienNASDAQ:ABEOAbeona Therapeutics Inc
02/01/20196:03AMGlobeNewswire Inc.Abeona Therapeutics présentera de nouvelles données de soutien pour les nouvelles thérapies géniques au WORLDSymposium™...NASDAQ:ABEOAbeona Therapeutics Inc
01/31/20198:00AMGlobeNewswire Inc.Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™NASDAQ:ABEOAbeona Therapeutics Inc
01/10/20195:03PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ABEOAbeona Therapeutics Inc
01/10/20198:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOAbeona Therapeutics Inc
01/08/20191:00PMGlobeNewswire Inc.Abeona Therapeutics Strengthens Financial Leadership with New Executive AppointmentsNASDAQ:ABEOAbeona Therapeutics Inc
12/06/20182:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOAbeona Therapeutics Inc
12/06/201812:30PMGlobeNewswire Inc.Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs and Unveils New Cystic Fibrosis Program Born from Ne...NASDAQ:ABEOAbeona Therapeutics Inc
11/30/20186:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOAbeona Therapeutics Inc
11/29/20188:45AMGlobeNewswire Inc.Abeona Therapeutics to Host R&D Day on December 6, 2018NASDAQ:ABEOAbeona Therapeutics Inc
11/26/20184:30PMGlobeNewswire Inc.Abeona Therapeutics Announces CEO TransitionNASDAQ:ABEOAbeona Therapeutics Inc
11/13/20188:45AMGlobeNewswire Inc.Abeona Announces Participation at the Jefferies 2018 London Healthcare ConferenceNASDAQ:ABEOAbeona Therapeutics Inc
11/12/201811:00AMGlobeNewswire Inc.Abeona Therapeutics annonce ses résultats financiers et les faits marquants du troisième trimestre 2018NASDAQ:ABEOAbeona Therapeutics Inc
11/12/201811:00AMGlobeNewswire Inc.Abeona Therapeutics gibt Finanzergebnisse und Geschäftserfolge des dritten Quartals 2018 bekanntNASDAQ:ABEOAbeona Therapeutics Inc
11/09/20184:52PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOAbeona Therapeutics Inc
11/09/20184:20PMGlobeNewswire Inc.Abeona Therapeutics Reports Third Quarter 2018 Financial Results and Business HighlightsNASDAQ:ABEOAbeona Therapeutics Inc
11/09/20184:20PMGlobeNewswire Inc.Abeona Therapeutics Reports Third Quarter 2018 Financial Results and Business HighlightsNASDAQ:ABEOAbeona Therapeutics Inc
11/09/20184:11PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABEOAbeona Therapeutics Inc
11/06/201811:33AMGlobeNewswire Inc.Abeona Therapeutics und REGENXBIO geben weltweite Exklusivlizenzen für die Behandlung von vier seltenen lysosomalen Speicher...NASDAQ:ABEOAbeona Therapeutics Inc
11/06/201811:33AMGlobeNewswire Inc.Abeona Therapeutics et REGENXBIO annoncent des licences mondiales exclusives pour le traitement de quatre maladies lysosomial...NASDAQ:ABEOAbeona Therapeutics Inc
11/06/20188:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOAbeona Therapeutics Inc
11/05/20187:00AMPR Newswire (US)REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Diso...NASDAQ:ABEOAbeona Therapeutics Inc
11/05/20187:00AMGlobeNewswire Inc.Abeona Therapeutics and REGENXBIO Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Diso...NASDAQ:ABEOAbeona Therapeutics Inc
10/18/20185:23PMGlobeNewswire Inc.Abeona Therapeutics ernennt Dr. João Siffert zum Leiter der Forschungs- und Entwicklungsabteilung sowie zum Chief Medical Of...NASDAQ:ABEOAbeona Therapeutics Inc
10/18/20185:23PMGlobeNewswire Inc.Abeona Therapeutics nomme João Siffert, M.D., comme Responsable recherche et développement et Directeur médicalNASDAQ:ABEOAbeona Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ABEO